Table 3.
Other Applications of Cellulose Blends in CDDSs
| Loaded Active Component |
Blend Composition | Duration of Release (Days) |
Therapeutic Effect | Ref. |
|---|---|---|---|---|
| BSA | MC/HA | >2 | Wound healing | 123 |
| Ibuprofen | HPMC/Eudragit | 1/2 | Improve patient compliance | 124 |
| DS | HPMC/Cedrela gum | 1/2 | Highly suitable for sustained drug release | 125 |
| Furosemide | HPMC/EC | >1/2 | Remarkable drug entrapment efficiency | 126 |
| Theophylline | HPMC/Psyllium | 1/2 | Suitable for sustained drug release | 127 |
| Cilostazol | HPMC/Carbomer | 1 | Improved plasma concentration and better bioavailability | 128 |
| Naproxen | EC/PVP | >3 | Wound healing | 129 |
| Isoliquiritigenin | HEC/HA | 1 | Enhanced skin permeation of the drug | 130 |
| FDZ and Bismuth(III) | CMC/SA | 1 | Treatment of gastrointestinal disorders | 131 |
| BSA | CMC/HA | 30 | Potential for cell encapsulation, regenerative medicine, and tissue engineering | 132 |
| BSA | CNCs/SA | 8 | Potential as drug carriers and wound dressing | 133 |
| Soil Nutrients | Cellulose/CS | 30 | Beneficial for agriculture and horticultural applications | 134 |
Abbreviations: FDZ, furazolidone; CS, chitosan; PEG, polyethylene glycol; ASCs, adipose-derived stem cells; Bfgf, basic fibroblast growth factor; HA, hyaluronic acid; TCH, tetracycline hydrochloride; BMP-2, bone morphogenetic protein-2; BSA, bovine serum albumin; PAM, polyacrylamide; SA, sodium alginate; PVA, polyvinyl alcohol; SA, salicylic acid; CDDS, controlled drug delivery system; PVP, polyvinyl propyl; HPMS, hydroxyl‐terminated polydimethylsiloxane.